Literature DB >> 8133981

Lamotrigine in Rett syndrome.

P Uldall1, F J Hansen, B Tonnby.   

Abstract

An elevated CSF glutamate level has recently been reported in Rett syndrome. Because the anticonvulsant effect of Lamotrigine is probably due to inhibition of glutamate release, this drug was given as an add-on drug to 4 girls with Rett syndrome. All patients responded with a seizure reduction of 50% or more and an improved well-being. A controlled study at the early stages of the syndrome could be interesting.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8133981     DOI: 10.1055/s-2008-1071568

Source DB:  PubMed          Journal:  Neuropediatrics        ISSN: 0174-304X            Impact factor:   1.947


  6 in total

Review 1.  Newer anti-epileptic drugs.

Authors:  S Aneja; R W Newton
Journal:  Indian J Pediatr       Date:  1996 Mar-Apr       Impact factor: 1.967

2.  Lamotrigine therapy for autistic disorder: a randomized, double-blind, placebo-controlled trial.

Authors:  K M Belsito; P A Law; K S Kirk; R J Landa; A W Zimmerman
Journal:  J Autism Dev Disord       Date:  2001-04

Review 3.  Newer anticonvulsants: comparative review of drug interactions and adverse effects.

Authors:  A Sabers; L Gram
Journal:  Drugs       Date:  2000-07       Impact factor: 9.546

Review 4.  Lamotrigine. An update of its pharmacology and therapeutic use in epilepsy.

Authors:  A Fitton; K L Goa
Journal:  Drugs       Date:  1995-10       Impact factor: 9.546

5.  The Antiviral Drug Tilorone Is a Potent and Selective Inhibitor of Acetylcholinesterase.

Authors:  Patricia A Vignaux; Eni Minerali; Thomas R Lane; Daniel H Foil; Peter B Madrid; Ana C Puhl; Sean Ekins
Journal:  Chem Res Toxicol       Date:  2021-01-05       Impact factor: 3.739

Review 6.  Management of epilepsy in patients with Rett syndrome: perspectives and considerations.

Authors:  Natalija Krajnc
Journal:  Ther Clin Risk Manag       Date:  2015-06-10       Impact factor: 2.423

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.